Monkeypox Assay Kit Comprehensive Study by Type (Routine Detection, Special Detection), Application (Hospital, Clinic, Other) Players and Region - Global Market Outlook to 2027

Monkeypox Assay Kit Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Monkeypox Assay Kit Market Scope
Assay kits are used in life science research, drug discovery & development, and environmental monitoring in a broad range of applications such as studying disease pathways, screening for potential drug candidates, and evaluating biopharmaceutical production processes. The Monkeypox Assay kit has been developed which can help to determine the disease at right time to help government bodies and hospitals to understand the course of treatment and avoid a further pandemic. The rise in cases and technological advancement has shown growth in the market. Also, governments are expanding the laboratories to fulfill the need for more and faster tests.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledRoche (United States), Trivitron Healthcare (India), BGI Group (China), Biochain (United States), Becton Dickinson (United States), Beijing Kinghawk Pharmaceutical Co.,Ltd. (China), Shenzhen New Industries Biomedical Engineering Co., Ltd. (China), Orient Gene Biotech (China), Biotest Biotech (China) and Wondfo Biotech (China)
CAGR%


The market has seen a massive investment in R&D and artificial intelligence which has driven the market growth. Massive investments and disruption of the digitization in industries due to pandemics in the market have seen a majority of providers enter the distribution channel has made it convenient to reach end-user. This has made it convenient for new entrances to grab a good position in the market as the government has shown positive support for expansion for testing infrastructure. Whereas the big players have tried to develop by mergers and acquisitions and investments in developing better technology to keep up with the competition and hold a higher position in the market. Research Analyst at AMA estimates that China Players will contribute to the maximum growth of Global Monkeypox Assay Kit market throughout the predicted period.

Roche (United States), Trivitron Healthcare (India), BGI Group (China), Biochain (United States), Becton Dickinson (United States), Beijing Kinghawk Pharmaceutical Co.,Ltd. (China), Shenzhen New Industries Biomedical Engineering Co., Ltd. (China), Orient Gene Biotech (China), Biotest Biotech (China) and Wondfo Biotech (China) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Shanghai Rendu Biotechnology Co Ltd (China), Beijing Bohui Innovation Biotechnology Group Co Ltd (China), Bioperfectus Technologies (China), Shanghai ZJ Bio-Tech Co., Ltd. (China) and Daan Gene (China).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Monkeypox Assay Kit market by Type , by Application (Hospital, Clinic and Other) and Region with country level break-up.

On the basis of geography, the market of Monkeypox Assay Kit has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2021.

Market Leaders and their expansionary development strategies
Becton Dickinson has partnered with CerTest Biotec to produce a molecular diagnostic test for the monkeypox virus. This new VIASURE Monkeypox CE/IVD test will be developed using the BD MAX open system reagent suite and validated on the BD MAX system. and The BD MAX system is an automated platform for nucleic acid extraction and real-time polymerase chain reaction (PCR) testing. It can provide results for up to 24 samples within three hours, making it an exceptionally efficient means of testing.
In June 2022 Department of Health and Human Services (HHS), through the Centers for Disease Control and Prevention (CDC), began shipping orthopoxvirus tests to five commercial laboratory companies, including the nationís largest reference laboratories, to quickly increase monkeypox testing capacity and access in every community during the ongoing monkeypox outbreak.


Monkeypox Assay Kit Market Dynamics:
AttributesDetails
Trends Influencing Market
  • There has been a Rise in the Number of Infections.
Key Restraints
  • Technology is Still in Development Due to Less Knowledge about Disease.
Challenges
  • High Initial Cost of Investments for R&D
  • The Time Taken for Approval of Devices is high.
Market Opportunities
  • Growing Development in Technology in Testing Kits to Have Better and Faster Results.


Key Target Audience
Pharmaceutical companies, New Entrants and Investors, Legalized Cannabis Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Type
  • Routine Detection
  • Special Detection
By Application
  • Hospital
  • Clinic
  • Other
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Investment for R&D in Pharmaceutical Industry Has Been Driving the Market.
    • 3.3. Market Challenges
      • 3.3.1. High Initial Cost of Investments for R&D
      • 3.3.2. The Time Taken for Approval of Devices is high.
    • 3.4. Market Trends
      • 3.4.1. There has been a Rise in the Number of Infections.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Monkeypox Assay Kit, by Type, Application and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Monkeypox Assay Kit (Value)
      • 5.2.1. Global Monkeypox Assay Kit by: Type (Value)
        • 5.2.1.1. Routine Detection
        • 5.2.1.2. Special Detection
      • 5.2.2. Global Monkeypox Assay Kit by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Clinic
        • 5.2.2.3. Other
      • 5.2.3. Global Monkeypox Assay Kit Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Monkeypox Assay Kit: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Roche (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Trivitron Healthcare (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BGI Group (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Biochain (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Becton Dickinson (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Beijing Kinghawk Pharmaceutical Co.,Ltd. (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Shenzhen New Industries Biomedical Engineering Co., Ltd. (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Orient Gene Biotech (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Biotest Biotech (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Wondfo Biotech (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Monkeypox Assay Kit Sale, by Type, Application and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Monkeypox Assay Kit (Value)
      • 7.2.1. Global Monkeypox Assay Kit by: Type (Value)
        • 7.2.1.1. Routine Detection
        • 7.2.1.2. Special Detection
      • 7.2.2. Global Monkeypox Assay Kit by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Clinic
        • 7.2.2.3. Other
      • 7.2.3. Global Monkeypox Assay Kit Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Monkeypox Assay Kit: by Type(USD Million)
  • Table 2. Monkeypox Assay Kit Routine Detection , by Region USD Million (2016-2021)
  • Table 3. Monkeypox Assay Kit Special Detection , by Region USD Million (2016-2021)
  • Table 4. Monkeypox Assay Kit: by Application(USD Million)
  • Table 5. Monkeypox Assay Kit Hospital , by Region USD Million (2016-2021)
  • Table 6. Monkeypox Assay Kit Clinic , by Region USD Million (2016-2021)
  • Table 7. Monkeypox Assay Kit Other , by Region USD Million (2016-2021)
  • Table 8. South America Monkeypox Assay Kit, by Country USD Million (2016-2021)
  • Table 9. South America Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 10. South America Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 11. Brazil Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 12. Brazil Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 13. Argentina Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 14. Argentina Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 15. Rest of South America Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 16. Rest of South America Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 17. Asia Pacific Monkeypox Assay Kit, by Country USD Million (2016-2021)
  • Table 18. Asia Pacific Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 19. Asia Pacific Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 20. China Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 21. China Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 22. Japan Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 23. Japan Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 24. India Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 25. India Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 26. South Korea Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 27. South Korea Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 28. Taiwan Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 29. Taiwan Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 30. Australia Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 31. Australia Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 32. Rest of Asia-Pacific Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 33. Rest of Asia-Pacific Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 34. Europe Monkeypox Assay Kit, by Country USD Million (2016-2021)
  • Table 35. Europe Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 36. Europe Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 37. Germany Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 38. Germany Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 39. France Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 40. France Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 41. Italy Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 42. Italy Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 43. United Kingdom Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 44. United Kingdom Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 45. Netherlands Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 46. Netherlands Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 47. Rest of Europe Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 48. Rest of Europe Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 49. MEA Monkeypox Assay Kit, by Country USD Million (2016-2021)
  • Table 50. MEA Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 51. MEA Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 52. Middle East Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 53. Middle East Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 54. Africa Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 55. Africa Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 56. North America Monkeypox Assay Kit, by Country USD Million (2016-2021)
  • Table 57. North America Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 58. North America Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 59. United States Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 60. United States Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 61. Canada Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 62. Canada Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 63. Mexico Monkeypox Assay Kit, by Type USD Million (2016-2021)
  • Table 64. Mexico Monkeypox Assay Kit, by Application USD Million (2016-2021)
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Monkeypox Assay Kit: by Type(USD Million)
  • Table 76. Monkeypox Assay Kit Routine Detection , by Region USD Million (2022-2027)
  • Table 77. Monkeypox Assay Kit Special Detection , by Region USD Million (2022-2027)
  • Table 78. Monkeypox Assay Kit: by Application(USD Million)
  • Table 79. Monkeypox Assay Kit Hospital , by Region USD Million (2022-2027)
  • Table 80. Monkeypox Assay Kit Clinic , by Region USD Million (2022-2027)
  • Table 81. Monkeypox Assay Kit Other , by Region USD Million (2022-2027)
  • Table 82. South America Monkeypox Assay Kit, by Country USD Million (2022-2027)
  • Table 83. South America Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 84. South America Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 85. Brazil Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 86. Brazil Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 87. Argentina Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 88. Argentina Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 89. Rest of South America Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 90. Rest of South America Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 91. Asia Pacific Monkeypox Assay Kit, by Country USD Million (2022-2027)
  • Table 92. Asia Pacific Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 93. Asia Pacific Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 94. China Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 95. China Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 96. Japan Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 97. Japan Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 98. India Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 99. India Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 100. South Korea Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 101. South Korea Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 102. Taiwan Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 103. Taiwan Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 104. Australia Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 105. Australia Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 106. Rest of Asia-Pacific Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 107. Rest of Asia-Pacific Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 108. Europe Monkeypox Assay Kit, by Country USD Million (2022-2027)
  • Table 109. Europe Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 110. Europe Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 111. Germany Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 112. Germany Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 113. France Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 114. France Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 115. Italy Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 116. Italy Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 117. United Kingdom Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 118. United Kingdom Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 119. Netherlands Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 120. Netherlands Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 121. Rest of Europe Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 122. Rest of Europe Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 123. MEA Monkeypox Assay Kit, by Country USD Million (2022-2027)
  • Table 124. MEA Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 125. MEA Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 126. Middle East Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 127. Middle East Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 128. Africa Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 129. Africa Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 130. North America Monkeypox Assay Kit, by Country USD Million (2022-2027)
  • Table 131. North America Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 132. North America Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 133. United States Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 134. United States Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 135. Canada Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 136. Canada Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 137. Mexico Monkeypox Assay Kit, by Type USD Million (2022-2027)
  • Table 138. Mexico Monkeypox Assay Kit, by Application USD Million (2022-2027)
  • Table 139. Research Programs/Design for This Report
  • Table 140. Key Data Information from Secondary Sources
  • Table 141. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Monkeypox Assay Kit: by Type USD Million (2016-2021)
  • Figure 5. Global Monkeypox Assay Kit: by Application USD Million (2016-2021)
  • Figure 6. South America Monkeypox Assay Kit Share (%), by Country
  • Figure 7. Asia Pacific Monkeypox Assay Kit Share (%), by Country
  • Figure 8. Europe Monkeypox Assay Kit Share (%), by Country
  • Figure 9. MEA Monkeypox Assay Kit Share (%), by Country
  • Figure 10. North America Monkeypox Assay Kit Share (%), by Country
  • Figure 11. Global Monkeypox Assay Kit share by Players 2021 (%)
  • Figure 12. Global Monkeypox Assay Kit share by Players (Top 3) 2021(%)
  • Figure 13. Global Monkeypox Assay Kit share by Players (Top 5) 2021(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Roche (United States) Revenue, Net Income and Gross profit
  • Figure 16. Roche (United States) Revenue: by Geography 2021
  • Figure 17. Trivitron Healthcare (India) Revenue, Net Income and Gross profit
  • Figure 18. Trivitron Healthcare (India) Revenue: by Geography 2021
  • Figure 19. BGI Group (China) Revenue, Net Income and Gross profit
  • Figure 20. BGI Group (China) Revenue: by Geography 2021
  • Figure 21. Biochain (United States) Revenue, Net Income and Gross profit
  • Figure 22. Biochain (United States) Revenue: by Geography 2021
  • Figure 23. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 24. Becton Dickinson (United States) Revenue: by Geography 2021
  • Figure 25. Beijing Kinghawk Pharmaceutical Co.,Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 26. Beijing Kinghawk Pharmaceutical Co.,Ltd. (China) Revenue: by Geography 2021
  • Figure 27. Shenzhen New Industries Biomedical Engineering Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 28. Shenzhen New Industries Biomedical Engineering Co., Ltd. (China) Revenue: by Geography 2021
  • Figure 29. Orient Gene Biotech (China) Revenue, Net Income and Gross profit
  • Figure 30. Orient Gene Biotech (China) Revenue: by Geography 2021
  • Figure 31. Biotest Biotech (China) Revenue, Net Income and Gross profit
  • Figure 32. Biotest Biotech (China) Revenue: by Geography 2021
  • Figure 33. Wondfo Biotech (China) Revenue, Net Income and Gross profit
  • Figure 34. Wondfo Biotech (China) Revenue: by Geography 2021
  • Figure 35. Global Monkeypox Assay Kit: by Type USD Million (2022-2027)
  • Figure 36. Global Monkeypox Assay Kit: by Application USD Million (2022-2027)
  • Figure 37. South America Monkeypox Assay Kit Share (%), by Country
  • Figure 38. Asia Pacific Monkeypox Assay Kit Share (%), by Country
  • Figure 39. Europe Monkeypox Assay Kit Share (%), by Country
  • Figure 40. MEA Monkeypox Assay Kit Share (%), by Country
  • Figure 41. North America Monkeypox Assay Kit Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Roche (United States)
  • Trivitron Healthcare (India)
  • BGI Group (China)
  • Biochain (United States)
  • Becton Dickinson (United States)
  • Beijing Kinghawk Pharmaceutical Co.,Ltd. (China)
  • Shenzhen New Industries Biomedical Engineering Co., Ltd. (China)
  • Orient Gene Biotech (China)
  • Biotest Biotech (China)
  • Wondfo Biotech (China)
Additional players considered in the study are as follows:
Shanghai Rendu Biotechnology Co Ltd (China) , Beijing Bohui Innovation Biotechnology Group Co Ltd (China) , Bioperfectus Technologies (China) , Shanghai ZJ Bio-Tech Co., Ltd. (China) , Daan Gene (China)
Select User Access Type

Key Highlights of Report


Jul 2022 249 Pages 81 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Monkeypox Assay Kit study can be customized to meet your requirements. The market size breakdown by type [Routine Detection and Special Detection], by end use application [Hospital, Clinic and Other].
The Monkeypox Assay Kit Market is gaining popularity and expected to see strong valuation by 2027.
  • Growing Investment for R&D in Pharmaceutical Industry Has Been Driving the Market.

Know More About Global Monkeypox Assay Kit Market Report?